Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Evansville
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Evansville, IN

Studies commonly pay $75 to $4,500 per completed study

68 clinical trials are currently recruiting participants within 30 miles of Evansville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

68studies recruiting
2+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Evansville right now

Top 25 of 68 recruiting studies, sorted by proximity — each links to its official registry page

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Owensboro Medical Health System ( Site 0066) — Owensboro, Kentucky (27.3 mi) · Sponsor: Merck Sharp & Dohme LLC

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung Phase 3 Interventional 830 participants sought
Research Site — Owensboro, Kentucky (27.3 mi) · Sponsor: AstraZeneca

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Osteoarthritis, Overweight or Obesity Phase 3 Interventional 900 participants sought
Qualmedica Research, LLC — Evansville, Indiana (1.5 mi) · Sponsor: Eli Lilly and Company

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Asthma Phase 3 Interventional 292 participants sought
GSK Investigational Site — Owensboro, Kentucky (27.3 mi) · Sponsor: GlaxoSmithKline

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

Asthma Phase 2 Interventional 69 participants sought
Research Site — Owensboro, Kentucky (27.3 mi) · Sponsor: AstraZeneca

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer Phase 3 Interventional 1,056 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: BeOne Medicines

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

Peripheral Arterial Disease Phase 3 Interventional 1,205 participants sought
Deaconess Clinic- Gateway — Newburgh, Indiana (7.6 mi) · Sponsor: Eli Lilly and Company

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Asthma Phase 2 Interventional 531 participants sought
Allergy & Asthma Specialists, P.S.C. — Owensboro, Kentucky (27.3 mi) · Sponsor: Eli Lilly and Company

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigative Site 9915 — Evansville, Indiana (1.5 mi) · Sponsor: Anthos Therapeutics, Inc.

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Evansville, Indiana (1.5 mi) · Sponsor: Alnylam Pharmaceuticals

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: NRG Oncology

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Pain N/A Observational 4,800 participants sought
Global Scientific Innovations - Advanced Pain Care Clinic — Evansville, Indiana (1.5 mi) · Sponsor: Boston Scientific Corporation

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Cardiovascular Disease Phase 3 Interventional 11,000 participants sought
MediSphere Medical Research Center LLC — Evansville, Indiana (1.5 mi) · Sponsor: Amgen

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile, Clostridium Difficile Infections Phase 3 Interventional 852 participants sought
Deaconess GI Specialty Center — Newburgh, Indiana (7.6 mi) · Sponsor: Vedanta Biosciences, Inc.

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Obesity, Overweight and/or Obesity Phase 3 Interventional 954 participants sought
MediSphere Medical Research Center, LLC — Evansville, Indiana (1.5 mi) · Sponsor: Pfizer

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Metabolic Dysfunction-Associated SteatoHepatitis (MASH) Phase 2 Interventional 120 participants sought
Deaconess Clinic - GI Specialty Center — Newburgh, Indiana (7.6 mi) · Sponsor: Regeneron Pharmaceuticals

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus Phase 3 Interventional 1,200 participants sought
Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Heart Failure and Impaired Kidney Function Phase 3 Interventional 4,800 participants sought
Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca

Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

Wheezing, Asthma Phase 3 Interventional 90 participants sought
Allergy and Asthma Specialist- Site Number : 8400002 — Owensboro, Kentucky (27.3 mi) · Sponsor: Sanofi
Actively enrolling

Studies you may be able to join near Evansville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Evansville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MediSphere Medical Research Center

★ 5.0
4411 Washington Ave Ste 147, Evansville, IN 47714
(812) 471-4110
"Good people who care about there people. For medical research ."
— Troy Christian, 5★

Qualmedica Research

5015 Plaza E Blvd, Evansville, IN 47715
(812) 205-2475

Clinical trials in Evansville: what's recruiting

The Evansville area currently has 68 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Evansville, the most active research areas are:

  • Cancer & Oncology6 studies
  • Diabetes & Metabolism4 studies
  • Lungs & Breathing4 studies
  • Heart & Vascular3 studies
  • Liver & Kidney3 studies

Every listing shows the study phase, the recruiting site and its distance from Evansville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Evansville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Evansville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Evansville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Evansville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Evansville, IN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Evansville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Evansville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Evansville typically complete one or two studies per year.

Paid clinical trials near Evansville

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IN

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts